Dr. Stefan Klingl

Dr. Stefan Klingl is Head of CMC at Plectonic Biotech, leading the Chemistry, Manufacturing, and Controls (CMC) strategy for DNA Origami therapeutics. With over 15 years of expertise in protein production and characterization and seven years in the biopharmaceutical industry, he has supported 15+ therapeutical projects from discovery to preclinical stages and brings extensive experience in biologics manufacturing, process development and developability assessment. He oversees the CMC manufacturing and regulatory strategy, selection of CDMO partners, and supports process development. Stefan earned his Ph.D. in Structural Biology from FAU Erlangen-Nürnberg, focusing on the structure-function relationship of viral effector proteins.